Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Evidence-based pharmacogenetic guidelines in the Netherlands

  • At: 2017 FIP Congress in Stockholm (Sweden)
  • Type: Poster
  • By: CHEUNG, Ka-Chun (Royal Dutch Pharmacists Association, Medicine Information Centre, DEN HAAG, Netherlands)
  • Co-author(s): Ka-Chun Cheung: Health research and innovation, Royal Dutch Pharmacists Association, DEN HAAG, Netherlands
    Marga Nijenhuis: Medicines Information Centre, Royal Dutch Pharmacists Association, DEN HAAG, Netherlands
    Mandy Crommentuijn – van Rhenen: Medicines Information Centre, Royal Dutch Pharmacists Association, DEN HAAG, Netherlands
    Inge Holsappel: Medicines Information Centre, Royal Dutch Pharmacists Association, DEN HAAG, Netherlands
  • Abstract:

    Backgrounds

    In recent years a number of scientific studies have shown that genetic variation in genes encoding drug transporters and drug metabolic enzymes affects drug disposition leading to under-dosing or overdosing in affected individuals. Drug response is a complex trait with significant interindividual variability. Therefore, application of..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses